Menu
Not yet recruiting NCT06709222

Robotic Rehabilitation and Dual-Task Exercises in Hemiplegic Patients

No phase Interventional Cognitive Coping Hemiplegia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: robotic rehabilitation, exercise.
Who it may be relevant to
Registry conditions: Cognitive Coping, Hemiplegia. Basic parameters: 30 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of the Effectiveness of Dual-Task Exercises Applied in Addition to Robotic Rehabilitation in Hemiplegic Patients: A Randomized Controlled Trial

Overview

The aim of this study was to investigate the effectiveness of dual-task exercises combined with robotic rehabilitation applied to post-stroke hemiplegia patients.

Detailed description

This research is designed as a randomized controlled experimental study. The study will be conducted on 40 hemiplegic patients. Participants will be randomly divided into two groups. Patients in the exercise group will be subjected to dual-task exercises together with robotic rehabilitation. Patients in the control group will be subjected to only the robotic rehabilitation treatment program. Both groups will be treated with 30-45 minute sessions, 3 days a week for 6 weeks. The exercises will be explained to the patients in detail one-on-one and repeated.

Interventions

  • Other robotic rehabilitation
    robotic rehabilitation
  • Other exercise
    dual-task exercises

Primary outcome measures

  • Timed up and go test [Time frame: 14 weeks]
  • Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline( total score is out of 30 points) [Time frame: 14 weeks]
  • Mini-Mental State Examination [Time frame: 14 weeks]

Eligibility criteria

Inclusion criteria

  • Diagnosis of post-stroke hemiplegia (hemiplegia onset must be between 3 months and 1 year).
  • Age range: 30-60 years.
  • Voluntariness to participate in rehabilitation.
  • Patients with a motor function loss of 30-70% according to Fugl-Meyer Motor Assessment results.
  • Literacy

Exclusion criteria

  • History of active psychiatric disease.
  • Severe joint deformities or other neurological diseases.
  • Having had a recent stroke during rehabilitation.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Sancak Medical Center — Istanbul

Publications

  • Li Y, Lian Y, Chen X, Zhang H, Xu G, Duan H, Xie X, Li Z. Effect of task-oriented training assisted by force feedback hand rehabilitation robot on finger grasping function in stroke patients with hemiplegia: a randomised controlled trial. J Neuroeng Rehabil. 2024 May 14;21(1):77. doi: 10.1186/s12984-024-01372-3. PMID 38745227
  • Ye JY, Chen R, Chu H, Lin HC, Liu D, Jen HJ, Banda KJ, Kustanti CY, Chou KR. Dual-task training in older adults with cognitive impairment: A meta-analysis and trial sequential analysis of randomized controlled trials. Int J Nurs Stud. 2024 Jul;155:104776. doi: 10.1016/j.ijnurstu.2024.104776. Epub 2024 Apr 18. PMID 38703695
  • Uysal I, Ozden F, Tumturk I, Imerci A. The effectiveness of dual task exercise training on balance, mobility, physical performance, and quality of life in children with cerebral palsy: a single-blind randomized controlled trial. Ir J Med Sci. 2024 Apr;193(2):813-821. doi: 10.1007/s11845-023-03530-3. Epub 2023 Sep 30. PMID 37777679

Identifiers

NCT: NCT06709222 · Uskudar17

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗